Smarter and more meaningful diagnostics...
With integrated position sensors, the Novacor Diasys 3 Plus transforms ABPM into a smarter, more clinically meaningful diagnostic – capturing not just numbers, but the full context behind blood pressure variability.
1
Position-Dependent Blood Pressure: A Critical Diagnostic Blind Spot
-
Blood pressure readings can vary significantly based on posture (standing, sitting, lying down), especially in patients with autonomic dysfunction, orthostatic hypotension, or nocturnal hypertension.
-
Without knowing the patient’s position, clinicians are left to guess whether a spike or drop in pressure is pathological or positional – which undermines diagnostic confidence.
2
Integrated Position Sensors: Real-Time Context, Greater Clinical Accuracy
-
The Diasys 3 Plus includes triple sensor technology that records the body posture at each BP reading—lying, sitting, standing or active, providing crucial context to interpret values.
-
This enables differentiation between true pathological hypertension and position-related variations, which is especially valuable in managing:
-
Resistant or labile hypertension
-
Elderly or frail patients
-
Diabetic patients at risk of autonomic neuropathy
-
3
Improved Clinical Decision-Making & Risk Stratification
-
Knowing whether a patient is upright or supine during a hypotensive event helps:
-
Avoid misdiagnosis (e.g., misattributing orthostatic hypotension to medication side effects).
-
Tailor antihypertensive therapy more precisely (e.g., timing or dosage adjustments based on nocturnal or postural trends).
-
-
This directly supports guideline-based management, such as those from the ESC or AHA, which emphasise nocturnal and positional BP patterns.
4
Enhanced Patient Engagement and Reporting
-
Coupled with the Diasys 3 Plus software, position-tagged data creates clear, visual reports that are easier for both clinicians and patients to understand and act upon.
-
The clear correlation between posture and readings can also help educate patients on lifestyle impacts of BP, boosting adherence and involvement in care plans.
5
Competitive Edge: Context-Aware Monitoring
-
Most ABPM devices on the market lack integrated posture tracking, leaving a critical data gap.
-
With the Diasys 3 Plus, you're not only getting validated ABPM and Arterial Stiffness assessment—but also a context-aware platform that delivers next-generation insight from the same test, with no extra effort from the provider or patient.
Empower your clinical team with more than just numbers. With the Novacor Diasys 3 Plus and its position sensor technology, transform ABPM into a smarter, safer, and more actionable tool—where every reading tells the whole story.
Non-invasive arterial stiffness assessment via QKD
The Novacor Diasys 3 Plus isn't just a blood pressure monitor – it's a clinically validated diagnostic tool that empowers early cardiovascular intervention through non-invasive arterial stiffness assessment.
1
QKD: A Differentiated Biomarker in Cardiovascular Risk Stratification
-
QKD (Quasi-continuous K-Distensibility) is a unique feature of the Diasys 3 Plus that measures arterial stiffness non-invasively during every measurement of 24-hour ambulatory blood pressure monitoring (ABPM).
-
Arterial stiffness is a well-established independent predictor of cardiovascular events, sometimes even more predictive than traditional risk factors.
-
QKD offers clinicians an accessible alternative to pulse wave velocity (PWV), integrating seamlessly with routine ABPM, unlike traditional stiffness measurement tools which are often separate, costly, or impractical in routine care.
2
Clinical Relevance & Guidelines Support
-
Arterial stiffness is increasingly recognized as a marker of subclinical target organ damage.
-
Current hypertension and cardiovascular prevention guidelines — such as those from ESH/ESC, AHA/ACC highlight arterial stiffness as an important prognostic marker for cardiovascular risk.
-
Higher arterial stiffness is strongly associated with increased risk of cardiovascular events, including:
-
Stroke
-
Heart attack
-
Heart failure
-
All-cause mortality
-
-
Older adults, diabetics, and those with resistant hypertension typically have increased arterial stiffness, making it a useful marker in these populations.
-
By offering arterial stiffness measurement (QKD) directly in the ABPM device, the Diasys 3 Plus allows early detection of vascular aging and refined cardiovascular risk stratification, directly influencing treatment decisions.
3
Ease of Use and Workflow Integration
-
Fully automatic, ambulatory, and validated, the Diasys 3 Plus integrates QKD into existing clinical workflows without adding procedural complexity or time burden.
-
The measurement requires no special training or additional hardware, making it ideal for primary care, cardiology, and nephrology practices alike.
4
Evidence-Based Differentiation
-
Unlike other ABPM devices, the Diasys 3 Plus has peer-reviewed support for its QKD methodology, with studies showing its correlation with invasive and imaging-based stiffness metrics.
-
This makes QKD a practical and reliable surrogate when more invasive or expensive options are unavailable.
With Novacor Diasys 3 Plus, you’re not just monitoring blood pressure you're enabling precision cardiovascular care by detecting vascular damage early, before clinical symptoms arise. Give your patients the benefit of tomorrow’s diagnostics today.
